English | 简体中文 | 繁體中文 | 한국어
Share:
Eastman Schedules Second-Quarter 2017 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast
Eastman Schedules Second-Quarter 2017 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast

Financial Results Release:  Thursday, July 27, 2017
Approximately 4:30 p.m. Eastern Time
Via wire distribution and www.eastman.com,
News Center and SEC Form 8-K filing.

 
Teleconference: Friday, July 28, 2017
8:00 a.m. Eastern Time
Via listen-only live webcast and teleconference.

 
  Live webcast: www.investors.eastman.com for link to the live webcast and to view the accompanying slides.
   
  Teleconference: Dial-in number 719-325-2213
Passcode: 7395643

 
Replay: A webcast replay, as well as a replay in downloadable MP3 format, will be available at www.investors.eastman.com.
   
  Telephone replay available continuously beginning at 11:00 a.m. Eastern Time, July 28, 2017 through 11:00 a.m. Eastern Time, August 7, 2017 at 888-203-1112 or 719-457-0820, passcode 7395643.

 

                                                          
                                                          
Investor Contact: Greg Riddle, 212-835-1620, griddle@eastman.com
Media Contact: Tracy Kilgore Addington, 423-224-0498, tracy@eastman.com      





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Eastman Chemical Company via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: